Key facts
- InkSpace Imaging’s last known valuation is $44.0M (Aug 2023).
- It has raised $22.1M across 1 recorded rounds; the latest was Early Stage VC ($12.0M) in Jul 2023.
- Notable investors include US National Science Foundation, MedTech Innovator, University of California, Berkeley SkyDeck, Berkeley — 10 tracked in total.
- InkSpace Imaging has filed 1 Form D with the SEC, most recently Aug 2023 ($12.0M sold to 43 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for InkSpace Imaging
Funding rounds
1 roundsAbout InkSpace Imaging
Developer of lightweight, body-conforming coils designed to enhance image clarity, workflow efficiency, and patient comfort in clinical and veterinary imaging. The company's coils specialize in being ultra-lightweight and contour the body for maximum image quality and quickly set-up times tailored for pediatrics, enabling pediatric patients with printed and flexible coils that ensure a systematic, comfortable fit to the patient for any size, shape, or body part.
- Sector
- Healthcare
- HQ
- Pleasanton, CA, United States
- Founded
- 2016
- Employees
- 21
- Website
- inkspaceimaging.com/
- Ownership
- Privately Held (backing)
InkSpace Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InkSpace Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InkSpace Imaging in its N-PORT filings yet. We sweep new filings monthly.